This inventor holds 1 USPTO granted patent. Top assignees: Bioalliance Pharma Sa, Centre National De La Recherche Scientifique. Active years: 2006.
Company Filing History:

Years Active: 2006
Title: The Innovations of Calude Malvy
Introduction
Calude Malvy is a notable inventor based in Boussy Saint Antoine, France. He has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotides. His work focuses on innovative methods for gene expression modulation, which has important implications for pharmaceutical applications.
Latest Patents
Calude Malvy holds a patent for "Oligonucleotides containing an antisense sequence stabilized by a secondary structure, pharmaceutical compositions containing them and method of blocking gene expression using them." This patent describes oligonucleotides capable of modifying or inhibiting in vivo or in vitro expression of a target gene. The oligonucleotide features an antisense sequence, at least one secondary structure, and optionally a supplementary nucleotide sequence. The secondary structure disintegrates upon attachment of the oligonucleotide to a target nucleic acid, making it a valuable tool in gene therapy.
Career Highlights
Throughout his career, Calude Malvy has worked with prominent organizations such as Bioalliance Pharma and the Centre National De La Recherche Scientifique. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Calude has collaborated with various professionals in his field, including Andrei Maksimenko. These partnerships have fostered innovation and the exchange of ideas, further enhancing the impact of his work.
Conclusion
Calude Malvy's contributions to biotechnology and gene therapy through his innovative patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence advancements in pharmaceutical compositions and gene expression modulation.